Next Oncology ( Site 0001) — San Antonio, Texas

Next Oncology ( Site 0001) is a clinical research site located in San Antonio, Texas, United States 78229.

Crixeo Health Trust Score: 56/100 (POOR). This profile has not yet been claimed by the site owner.

Next Oncology ( Site 0001) has participated in 2 clinical trials.

Therapeutic areas: Neoplasms, Solid Tumors.

Sponsors: Merck Sharp & Dohme LLC.

Sponsor Feasibility Report

Trust Score: 56/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Next Oncology ( Site 0001)?

Next Oncology ( Site 0001) has a Crixeo Trust Score of 56/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Next Oncology ( Site 0001) conducted?

Next Oncology ( Site 0001) has 2 clinical trials on record. Their work covers Neoplasms, Solid Tumors.

Is Next Oncology ( Site 0001) accredited by Crixeo Health?

Next Oncology ( Site 0001) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Next Oncology ( Site 0001)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.